The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
Due to the COVID-19 pandemic, meetings may be virtual in 2021.
June 2021
BCMA Targeted Therapies Summit
June 21-23, 2021| Online Event
Built with thought leaders from Seattle Genetics, Precision Biosciences and Kite Pharma, the inaugural industry-focused BCMA Targeted Therapies Summit will share the field’s cutting-edge and aggressive scientific advances of BCMA therapies within multiple myeloma.
This summit is the first of its kind, uniting thought leaders in BCMA therapeutics drug development to discuss their challenges and future directions, with the aim to overcome key obstacles when designing a clinical trial, addressing the rationale for combinations and determining mechanisms of relapse.
Access the full agenda and world class speaker faculty here.
The race for the next approval may be on but make sure you join over 80 of your peers at the only definitive digital platform dedicated to bringing together BCMA experts from large pharma, innovative biotech, research institutes and most importantly, the end users; the patients to participate in cross-disciplinary discussions. Whether you’re developing an ADC, a CAR-T or a Bispecific for the BCMA Target, this is the meeting for you.
Leave this comprehensive forum equipped with novel ideas, actionable lessons learned and new connections. Don’t miss your opportunity to be a part of the force accelerating the development of BCMA targeted therapeutics.
For more information, view your full event guide.
Antibody Society Members save 10% on registration for this virtual event – Contact us at membership@antibodysociety.org for the discount code!
Antibody Industrial Symposium (virtual)
June 22-25, 2021
The 9th Antibody Industrial Symposium AIS2021 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 22-25 2021, virtually. This year edition will focus on Therapeutic Antibodies & derivatives formats , Ab-like Molecules, Adoptive Cell Therapy and other innovative ATMPs for fighting Diseases. It includes keynote lectures, pitch talks around new creative projects, industrial talks from big pharmaceutical companies and dedicated poster session.
Moreover, the program will allow opportunities for one-to-one meetings, companies to showcase their new products and technologies virtually as well as dedicated time for business partnering.
Antibody Society Members save 20% on registration for this virtual event – Contact us at membership@antibodysociety.org for the discount code!
July 2021
June 30 – July 1, 2021
Taking place as a fully interactive virtual meeting, the 3rd Cell Engager Summit is the only industry-led meeting focused on developing multi-specific cell engaging therapies in solid tumor indications, and accelerating early discovery innovation into the clinic.
Whether you’re undertaking exploratory research or assembling data for regulatory review, this is the best chance you will get all year to network with dozens of pioneering cell engager drug developers including Maverick, Merus, Sanofi, Roche, Pfizer, Takeda, Pieris, Xencor, TeneoBio, IGM Biosciences, Regeneron, EMD Serono, Harbour Biomed, and more.
Access the full conference agenda and speaker line-up here
Join us as we explore the underpinning biology of the tumor microenvironment, the immune system, and overcome the challenges that obstruct the development of therapeutics from bench to bedside. You’re guaranteed to walk away with actionable insights to harnessing the power of immune cell engagement to advance next-generation cancer treatments to market.
Download the full event guide here for details.
Our Members Save 10% – Contact us at membership@antibodysociety.org for the discount code!
PEGS Summer Symposium – Virtual
July 19-22, 2021
Keeping the PEGS Community Connected, the Conversation Going and Breakthrough Research Evolving
PEGS Summer Symposium is a 4-day, 4-part topic-focused series that will feature the latest biotherapeutics research and strategies for accelerating biologics development.
This symposium is an opportunity to share ideas and challenges openly with peers. The experience will be enhanced by the quality, energy and diversity of the people participating.
Register for a single day or attend all 4 days and gain access presentations from industry experts working across the entire spectrum of biopharmaceutical development and production. These resources will be available on-demand for all registered participants.
Our Members Save 20% – Contact us at membership@antibodysociety.org for the discount code!
September 2021
September 29 – October 1, 2021
The 12th Annual World Bispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique discovery, translational, and manufacturing challenges faced in the bispecific field. Whatever your role and interest, you will leave the meeting with concrete methods to employ into your strategy and pipeline to convert the promise of bispecific therapeutics into a reality for patients.
Discover who the 45+ expert speakers are, and the topics they will examine, including how:
OSE Immunotherapeutics is pioneering their unique platform BiCKI a bispecific platform optimized for the development and manufacturing of bispecific cytokine fusion proteins
GT Biopharma and Light Chain Bioscience are showcasing the next generation of innate cell engagers for the treatment of solid tumors
Merus, Pfizer, and Innate Pharma are expanding the boundaries of biotherapeutics with tri-specific and multi-specific antibodies
Genentech, Pfizer, and City of Hope are discussing approaches to reduce on-target off-tumor toxicities including dosing strategies in liquid and solid tumor indications
Xencor, Harbour Biomed, and Harpoon Therapeutics will discuss their unique platforms and CMC strategies for scale-up and production
IGM Biosciences and MacroGenics will evaluate biomarker strategies for bispecific candidates during clinical development
Access the event guide and registration site here!
The Antibody Society Members Save 10% – Contact us at membership@antibodysociety.org for the discount code!
October 2021
12th World ADC San Diego, Digital Edition
October 11-14, 2021
Covering the A to Z of ADCs, World ADC San Diego is the industry’s most comprehensive and detailed learning experience with built-in networking opportunities. As we reflect on 2021, the global ADC renaissance has been truly exciting to see. The growth and comeback of the ADC community has resulted in an abundance of new data, innovative insights and valuable lessons learned, all of which will be shared at the 12th World ADC San Diego – the Digital Edition.
Check out your full guide for the 90+ world class leaders
Designed with AbbVie, Genentech, Daiichi Sankyo, Seagen and ImmunoGen, this leading forum will once again equip you with the knowledge and connections that will enable you to maximize the clinical therapeutic window of your ADC candidate. With 5 tracks of dedicated content, this is the perfect intensive crash course for experts across your team to get up to speed with the latest ADC developments from discovery to commercialization in just 4 days.
For more information, view your full event guide.
Join teams from leading companies online to uncover the secrets behind developing more clinically effective ADCs, and tailor the experience to meet your needs as you prepare for the next steps in your ADC journey.
The Antibody Society Members Save 10% – Contact us at membership@antibodysociety.org for the discount code!
November 2021
Festival of Biologics Basel
November 9-11, 2021
The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market.
